CTLA4 and myasthenia gravis: Application of cytotoxic T-lymphocyte associated protein 4 (CTLA-4) and PD-1 inhibitors together was negatively related to an unfavorable outcome for ICI-related MG (OR = 12.142, p = 0.050).